Upcoming Events

Clinical Microbiology is the most fundamental branch in the field of Medical Science that focus on the cause, diagnosis, treatment, and prevention of infectious diseases and different clinical applications of some beneficial microbes for the improvement of health in today’s world.

LexisConferences Conferences feels immense pleasure to invite you to Clinical Microbiology Conference 2019 that provides a platform with its well organized scientific program for the audience which includes Keynote session, Panel discussions, Plenary talks, Poster sessions, Exhibitions, Workshops, etc. The gathering involves the expertise in the field of Microbiology, Virology, Bacteriology, Parasitology, Mycology, Pathology, Pharmacy, Epidemiology, Health-Care and all young researchers and enthusiasts in the related fields.

ME Conferences merrily welcomes you to attend “2nd International Conference on Pharmacology and Toxicology” during December 09-10, 2019, at Dubai, UAE with a theme of Widening the possibilities in Pharmacology and Toxicology. ME conferences is an Open Access Initiative is committed to making genuine and reliable contributions to the scientific community.

On behalf of the organizing committee, we take this opportunity in extending a warm and cordial welcome to you to be a part of the Pharmacology and Toxicology. World Pharmacology 2019 conference is scheduled during December 09-10, 2019, at Dubai, UAE. This conference aim is to gather the most elegant societies and industries along with the renowned and honorable persons from top universities across the globe. The World Pharmacology 2019 organizing committee is confident that participants will get benefits from this high-value scientific program. We welcome all the researchers/ academicians join us at Dubai, UAE.

Pharmacology is integrative of fields like biochemistry, toxicology, genetic engineering, molecular engineering and its advancement using nanotechnology. Pharma includes health care contribution to drug development and discussed research and innovative works in the pharmacy field. During this conference, the international symposiums, B2B meetings, international workshops will also be organized to discuss the specific topics in the field of pharmacology and toxicology. The conference also welcomes International exhibitions form corporate sectors to showcase the recent advancements in the tools and techniques. In all its ways World Pharmacology 2019 creates an opportunity to make partnership deals which will turn into a cent percent success meet.

Find the latest science, technology and partners in antibody engineering, immunobiology and next generation binders

This December, 60+ thought-leaders including neuro-oncologists, neurosurgeons and oncology professionals from biopharma will be converging at the first industry led Glioblastoma Drug Development Summit under a common goal of accelerating the practical discovery, translation and clinical development of safe, effective and deliverable therapies to treat glioblastoma.

This meeting provides a truly unique platform for discussions aimed specifically at helping you not only successfully translate drug candidates into human clinical trials, but optimize the clinical development itself to avoid more clinical failures.

Gain exclusive insights into tackling specific and applied drug development challenges limiting effective therapies. This includes tumor heterogeneity, redundant pathway signalling, the immunosuppressive tumor environment and penetration through the blood-brain barrier.

With an increasing number of failed phase II trials and a very poor standard of care, there has never been a more important time to attend the Glioblastoma Drug Development Summit and join those striving to advance safe and effective therapeutic breakthroughs to patients in need.

The Drug Delivery to the Lungs (DDL) Conference provides an annual forum for scientists, academics, clinicians, regulatory and industry specialists involved in developing medicines for inhalation.

DDL2019 will have five themed sessions each with a combination of invited and submitted lectures given by experts in the field of inhalation and students working to advance respiratory science.  Alongside the lecture programme is a large industry exhibition and inhalation science poster exhibition.

The 14th Biosimilars Congregation 2019 will be your opportunity with leading industry experts to discuss from development, manufacturing to commercialization - The current landscape, legal, regulatory, funding, challenges, market access strategy, business models and how to get to market

Virtue Insight is delighted to invite you to attend the 14th Biosimilars Congregation 2019 conference, to be held on 12th December 2019 in Mumbai, India. 14th Biosimilars Congregation 2019 brings together scientists, researchers and CROs from around the world.

At 14th Biosimilars Congregation 2019 meet your target audiences from around the world focused on learning about biologics and biosimilars. This conference would be your single best opportunity to reach the largest assemblage of participants from the biologics and biosimilars community

The investor conference that drives the future of drug development. More than $330 billion in capital represented.

SMi is proud to present the 12th Annual Pre-Filled Syringes and Injectable Drug Devices Conference in London on 15th and 16th January 2020.

As Europe’s leading PFS conference and given the key factors driving the market, we will assess innovations in design controls and applications, enhancement of human factors and optimizing formulation and containment.

The rapid expansion of the PFS market and the regulatory environment are more important than ever, this year’s programme will look at the EU MDR, Article 117, ISO change management standard as well as insights into the MDR post-market safety report, providing a holistic review of the Pre-Filled Syringes industry.

This two-day agenda offers you peer-to-peer networking with Global Product Managers, Senior PFS Engineers, Device Testing Managers, Heads of Late-Stage PFS Development and many more.

We look forward to welcoming you to the conference in January.

This is our most sought-after event and will be sold out soon.

We are delighted to invite you to the 10th Emirates Otorhinolaryngology Audiology and Communication Disorders Congress in combined meeting with Russian ORL , Italian Society of ORL & Head and Neck Surgery and Japan ORL. This year, it will be a joint meeting with 2nd International Sialendoscopy Conference. The congress has been comprehensively organized to capture the excellent innovations which would cover all aspects of Otorhinolaryngology, Audiology & Communication Disorders. The Congress will be held in Dubai, UAE from 15-17 January 2020, at the Intercontinental Hotel, Dubai Festival City.

The 2020 congress will also have several live surgical pre-congress workshops on state of the art anatomical specimens. From the wide array of presentations submitted to us by the research committee, the scientific committee will choose the best ones to be presented during the congress and the best presentations will be recognized and awarded.

We have kept the registration fee at affordable rates to encourage the participation of young & upcoming practitioners and scientists. The congress venue is conveniently located in the center of the city, close to the airport, metro stations and shopping destinations. We have great pride in welcoming you to Dubai, the true cosmopolitan city of the world, offering a kaleidoscope of attractions. We are confident that this congress will exceed your expectations, offering an exciting scientific event as well as an enjoyable social and cultural experience.

We look forward to meeting you all in Dubai in January 2020 for one of the best scientific gathering in the region.

The age of digital medicine is here!

McKinsey estimates that big data and machine learning could generate up to $100bn in pharma and medicine annually. There has never been a more pressing need for pharma to transition to digital as existing technologies are being disrupted by Artificial Intelligence, Machine Learning, Virtual Reality, Internet of Things and Blockchain, while newer categories such as Prescription Digital Therapeutics begin to offer truly disruptive benefits.
 

As new technologies are being incorporated into pharma it is crucial, we reflect on trends in cutting-edge innovation and explore new tech-enabled opportunities to cut costs and save time.

Partnerships are at the heart of digital transformation. Innovative approaches to partnerships are leading the way towards more effective data collection, faster R&D, seamless clinical trials and above all, more patient-centric medicine.

Pharmaceutical Microbiology as an industry is projected to see significant advancements in the next five years. This forecast is largely attributed to rapid microbiology testing, which has accounted for $3.5 billion last year, while projected to reach nearly double at $6 billion by 2025, and an estimated CAGR of 8.3% leading up to 2025.

At the very core of pharmaceutical microbiology is the accurate and reliable detection of microorganisms that would otherwise contaminate the pharmaceutical products manufactured. This demand for more rapid methods for detection and identification will be accompanied by equally important areas such as: contamination control strategies and environmental monitoring, process automation, and discussing updates to meet regulatory requirements.
 

Join us this year to explore novel and developing technologies that tackle the most pressing challenges and push innovation in world of pharmaceutical microbiology.

Global Pharmaceutica 2020 covers various aspects of Bio-Pharmaceutics, Pharmaceutical Chemistry, Drug Targeting and Design, Pharmacokinetics and Pharmacodynamics in Drugs, Pharmaceutical Formulation, Pharmaceutical Manufacturing, Pharmaceutical Nanotechnology, Novel Drug Delivery Systems, Smart Drug Delivery Systems, Nanomedicine and Biomedical Applications, Biomaterials in Drug Delivery, Vaccine Drug Delivery Systems, Medical Devices for Drug Delivery, Biologics & Biosimilars, Pharmaceutical Analysis, Pharmaceutical Process Validation, Pharmaceutical Packaging, Clinical Trials and Clinical Research, Pharmacogenetics and Genomics, Regulatory Affairs and Intellectual Property Rights, Industrial and Physical Pharmacy, Clinical and Hospital Pharmacy, Pharmacovigilance and Drug Safety, Pharmacy Education and Practice

The 12th REMS Summit convenes pharma, FDA, healthcare providers, and patient advocates to delve into specific topics to enhance the understanding of when REMS are necessary the elements that need to be included in the REMS needed for their product, as well as details required for submission. Our adept speaking faculty will arm you with proven strategies to facilitate benefit-risk counseling, optimize REMS operations through streamlined health system integration, leverage interoperable technologies for consistent communication, and increase patient safety through cross-functional collaboration.

Within the PREDiCT series, Tumor Models San Francisco stands out as the primary platform for Immuno-Oncology research. Offering tailored insights for the unique field, as well the opportunity to debate the niche topics that are currently hot within the field right now.

This summit is dedicated to scientists trying to select the right IO candidates, improve the efficiency with which they advance through preclinical trials without compromising safety, and more accurately translate from murine models into humans using both current and more novel technologies.

Patients as Partners EU is the first European event to help incorporate the voice of the patient throughout medicines development. This 4th annual program’s core theme emphasizes bringing value back to patients.

The program is co-produced with industry, patient advocacy and public sector voices to implement and advance patient involvement across the entire clinical development continuum. Each session puts ideas into action and demonstrates the what, where, when and how behind the topic.

The 2020 program features an outstanding line-up of new sessions, led by both patients and industry, and includes a series of formats with multi-stakeholder perspectives.

Four years in the drug development world isn’t long, and the progress made in continuous processing has been an extraordinary. Thanks to the encouragement of the FDA and maturing technology; both pharma and biotech are starting to adopt continuous manufacturing (CM) in a commercial setting.

Over the last 12 months we have seen major milestones in continuous manufacturing globally – PROSPECT project in the UK, GSK’s announcement of CM facilities in Singapore, Merck has filed an NDA under CM approach, Bill & Melinda Gates Foundation granted $14.3m to Univercells to deploy CM for measles and rubella vaccine continuous manufacturing.

At the 4th Annual CCP Summit we will continue to explore scientific and technology advancements that can help eliminate bottlenecks, and more importantly, will address the quality, upfront investment and business rationale behind the ‘switch’.

Join us at the 2020 National Manufacturing Conference & Exhibition on the 29 – 30 of January to hear from an impressive line-up of manufacturing leaders, academics and government agencies who will engage in a stimulating blend of key note addresses and debates.

We enable deeper learning, relationships and decisions through offering an all-important platform empowering 25,661 professionals with enhanced business opportunities and realised innovation.

Long established as the ‘must attend’ event in the region, Medlab Middle East is where the world of laboratory medicine meets.

We’re at the very heart of the sector, and a healthy healthcare sector is a healthier world for all. So we’ll continue to build on our responsible position, playing our part to help everyone connected to healthcare make real progress.

SMi presents Europe's leading 14th annual Parallel Trade conference, taking place in London on the 4th-5th of February 2020. As the only  B2B parallel trade conference in Europe, this event provides the perfect platform for industry experts from both sides of the coin to come together and share perspectives on the practice of parallel trade.

The size of the EU market in pharmaceutical distribution is around €5bn, and the UK accounts for 22.7% of this figure. The sector has an annual import value of around £1bn, while the annual export figure approximates £600m.

The 2020 event will hold a particular place of significance on shortages of medicines, current and ongoing challenges posed by Parallel Trading, potential implications of Brexit and IP exhaustion rights.

Furthermore, the FMD (Falsified Medicines Directive) will be coming into effect in February 2020. This conference will give companies affected the perfect opportunity to discuss and consider the impact that the FMD implementation will have on their practices and on the market.

The 1st Summit will be held February 5-7, 2020 in Carlsbad, California. The agenda will be educational, innovative and developmental of new approaches and collaborations. The Attendees will include all multilevel and multidisciplinary stakeholders in this space and will include a diverse group of scientists, clinicians, regulators, corporate, private equity and venture capitalists.

The growing potential of blockchain applications needs no introduction these days. It has the potential to revolutionise the healthcare industry, and to be a part of this revolution it is crucial for you to first understand the nature of blockchain technology.

At Blockchain in Healthcare Congress, you will hear experts from international healthcare organisations, academic and companies at the leading edge of technological solutions. They will help you to distinguish the hype from the reality and then to hear real-world case studies of how blockchain can be and is being, applied to healthcare systems.

The meeting is co-located with the 2nd Global Cyber Security in Healthcare & Pharma Summit and your pass will also give you full access to this meeting. In addition, you have the option to attend the H-ISAC (Health Information Sharing and Analysis Center) London Workshop: Healthcare Cybersecurity

The importance of cybersecurity and the growing potential of blockchain applications need no introduction these days.

Anybody with responsibility for security, IT, e-health, medical devices and innovation in the health sector must be prepared to meet the challenges and opportunities presented by both of these elements.

At the Global Cyber Security in Healthcare and Pharma Summit, you will hear experts from international healthcare organisations, academic and companies at the leading edge of technological solutions.

The meeting is co-located with the 2nd Blockchain in Health Congress and your pass will also give you full access to this meeting.

This two-day meeting has been purposely designed to facilitate collaboration and attract attendance from multiple stakeholders including KOL, investigators, academia, pharma, providers and regulators. The conference will examine the latest research and development in pathogenesis, diagnosis and treatment of the disease. As well as exceptional speaker presentations the meeting features 10 roundtable discussions. Each is led by an expert to provide you with a unique opportunity to debate the issues in areas such as the regulatory challenges for FDA approval, NASH and Diabetes and Preclinical models, to name just four.

It is the course’s goal to inform about the latest developments in serialisation & authentication coming from the European and International Regulations such as the Russian Crypto Coding requirements, the EU Directive 2011/62/EC and corresponding Delegated Regulation and the US Drug Supply Chain Security Act (DSCSA). Also, the Medical Device Regulation (EU) 2017/745 coming into force on 26th May 2020 and the UDI-marking requirements in Europe and US will be dealt with. Generally, the challenges and solutions how to comply with serialisation, tamper verification and packaging requirements of medicinal products and the requirements of Medical Devices and Unique Device Identification in the different markets are core content of this course. Best practice examples will demonstrate how the new European and International requirements on verification of the authenticity of each single medicinal product and the new regulations on medical devices can be put into practice. This course will also explain requirements for Artwork Management, Packaging specification and typesetting.

The training course will support you in collecting, sorting and proper understanding of the requirements of the serialisation Requirements in Russia, in Europe, the US and other markets and the Medical Device Regulation. This includes the relevant information related to the Russian Crypto Coding, the defined two EU-safety features (unique identifier and tamper evident closure) and the US and International serialisation requirements. Also, this course will deal with the existing and emerging global serialization and track and trace requirements for medicines and their packaging in markets such as China, Korea, US and others. This course will also deal with Artwork Security and Audit Trails of Artworks Management.

Scripps MD Anderson Cancer Center’s Clinical Hematology & Oncology Conference 2020, is designed for hematologists, oncologists, surgeons, radiation oncologists, internists, and others desiring an update in these specialty areas. The primary objective of this course is to bring together clinicians and leading experts in diverse areas of hematology and oncology, affording them an intimate environment in which to discuss new clinical developments and significant advances.

Gynecology 2020 destine to endeavor leading-edge memoranda of eminent keynote speakers, universal personalities, special sessions and poster presentations attracting experts in Gynecology and Obstetrics field. This conference has been designed to bring out the ravishing ideas where it takes up a Gynecology field to the next set of standards. inclusive of enlightening presentations and discussions, we have planned to offer a chance to organize a workshop.  

The core objective of this event is to empower and bring about maximum exposure to our attendees, so we make sure that this event is a blend which covers professionals such as Gynecologist, obstetricians, paediatrician, oncologist, physicians, medical assistants, midwives, nursing assistants, Health Care Administrator, nutritionist, therapists, medical secretaries, women health care professionals and students with wide knowledge, choices and recommendations that will support them; make them more informed about healthcare and make better decisions in managing reproductive health of women.

Gynecology 2020 is setting its scaffold in France to present  and bring about the researchers of  Gynecology and Women Health under one crown by providing opportunities to Young Researchers, to meet and socialize with the experts to establish global network.

We hope that you will join us in the Paris and make up your precious time to share your experience and research work  to lead the future in Gynecology and obstetrics field.

The 15th Annual Biomarkers Congress is part of the Biomarkers Series UK, new for 2020 also encompassing the Genomic Markers Congress and a Pre-Event Focus Day featuring Deep-Dive Therapeutic Focus Sessions and End-User Workshops

SMi Group announces the 11th Annual RNA Therapeutics Conference in London on February 19th - 20th 2020.

The field of RNA therapeutics is rapidly expanding, and the potential for using RNA drugs for personalised medicines and immunotherapy, as well as to address genetic, infectious and chronic diseases will ensure the continued development of RNA therapeutics for years to come.

The global antisense and RNA therapeutics market size is expected to expand at a compound annual growth rate (CAGR) of 8.6% between 2019 and 2025, when it is projected to reach $1.81 billion. RNA-based drugs, including short interfering RNAs and antisense oligonucleotides, are particularly promising examples of this newer class of biologics. For over two decades, researchers have been trying to overcome major challenges for utilizing such RNAs in a therapeutic context, including intracellular delivery, stability, and immune response activation. Furthermore, the recent advent of CRISPR, an RNA-guided gene-editing technology, as well as new strides in the delivery of messenger RNA transcribed in vitro, have triggered a major expansion of the RNA-therapeutics field.

This year, we will maintain our focus on the latest research and developments on delivery system technologies that aim to tackle more difficult targets within the human body. This overarching topic warrants high focus and therefore we will, for the first time in the series, introduce a focus day on Oligonucletide Delivery Systems. Our main conference will focus on current developments in the area of mRNA therapeutics in immunotherapy and vaccination. We will also cover a fair bit of regulation, such as continuing upon patenting novel products, release of new 2020 regulations in the clinical trials arena, as well as ensuring compliance. Finally, a significant section that tackles novel and emerging therapies as well as the latest research findings from academia will also be present in this year’s agenda.

Join us in February 2020, as SMi’s RNA Therapeutics Conference brings together industry experts from leading RNA therapeutics companies to discuss the challenges for clinical translation of RNA-based therapeutics, with an emphasis on recent advances in delivery technologies, and present an overview of the applications of RNA-based drugs for modulation of gene and protein expression, and genome editing.

Cell Culture in an important tool for research and development within the life science industry. OThe global 3D Cell Culture Market market is valued at USD 1069.28 Million and is expected to grow with a CAGR of 25.31% over the forecast period. Researchers globally are realizing the potential of 3D cell culture for various applications, including models for personalized medicine, complex and multi-cell type models, translation and clinical and industrial applications.

Over the past few years, 3D Cell Culture has gained momentum within the pharmaceutical industry due to the benefits that this model offers for in vitro applications patient-derived tissues, drug discovery, predictivity and validation, and safety and toxicity.

SMi’s 3D Cell Culture conference will explore advances of organ and lab-on-a-chip, microphysiological systems, applications of technology and case studies, imaging, high throughput screening and advances in 3D cell culture models which make up core components within the 3D Cell Culture field.

2nd European Biotechnology Congress is the world’s leading conference for all professionals to gather and contribute their research. Biotechnology Congress 2020 offers over 10 sessions from different areas in the field of Biotechnology in the form of Keynote, Plenary and workshop sessions including oral and poster presentations.
 

2nd European Biotechnology Conferences which is going to be held in global city February 19-20, 2020 during Paris, France will address fast growing technologies in the field of biotechnology with significant opportunities for Biotechnology Conferences.  2nd European Biotechnology Conferences will bring together practitioners, researchers, clinicians in a universal forum, enabling the exchange of novel advancement in the field of Biotechnology in both science and practice. Biotechnology Congress 2020 is the best place to enhance networking and would provide opportunity to interact with world’s leading scientists and researchers.

On 20 & 21 February 2020, Lisbon (Portugal) will host the BioTech Pharma Summit: Liquid Biopsy 2020 conference. This year’s event will bring together the leaders in the field from pharma, biotech, Dx companies and healthcare and be the home of multi-stakeholder and pan-industry collaboration for liquid biopsy, molecular pathology and precision medicine experts to explore the expanding and evolving field whereby Circulating Biomarkers of various classes are being evaluated for their potential to be developed into diagnostics for cancer as well as application of liquid biopsy testing, across biofluids, biomarkers and disease indications, as the needle shifts on the gold standard of personalized healthcare testing.

The field of liquid biopsy is moving beyond isolation and characterization of CTCs and ctDNA to surveillance, early detection of relapse and minimal residual disease, and interventional studies in clinical applications. The scope of the conference encompasses circulating tumor cells, cell-free circulating DNA, exosomes and extracellular vesicles. This meeting has become an important annual event for leaders in the community to discuss the tools, validation and implementation of circulating biomarkers, which are transforming our understanding and management of disease.

The BioTech Pharma Summit: Liquid Biopsy 2020 focuses primarily on biofluid-based molecular biomarkers, such as circulating tumor DNA (ctDNA) as well as circulating tumor cells (CTCs), and protein-based circulating biomarkers. There is much interest in the potential of ctDNA for developing biological fluid-based biopsies (such as using plasma, urine, or other biofluids) and the presenters in this track bring together the most up-to-date information and current state-of-the-field.

The Digitalization in Pharma Forum organized by GLC Europe will provide a great opportunity for learning and networking during the 2 days of the event. The goal of the conference is to uncover the insights of the most emerging best practices and industry expertise in the field digitalization in the pharmaceutical sector.

Is your goal to possess the most insightful information about the digital marketing trends in pharma? Would you like to know more about the connected multichannel? Do you strive to discover the latest updates and insights from market leaders on the new production technologies? Would you like to discuss the challenges of transforming healthcare with fellow professionals?

Join us in February 2020 in the beautiful Berlin and get your unique chance to get updates, learn, network, and extend your professional horizons.

The European Clinical Quality Risk Management Forum in London on 24–25 February, provides a forum for senior-level clinical quality, compliance and operations executives from leading pharma, biotech and medical device companies, to candidly discuss strategies for ensuring trial integrity through proactive clinical risk management.  Learn from this experienced group and take-away proven, results-driven, risk-based strategies for optimizing your company’s clinical quality to achieve a continual state of inspection readiness.

The 3rd Annual AI-ML: Drug Discovery & Development Summit is the industry’s definitive guide to translating the wealth of tech available to successful, efficacious and efficient R&D processes. With 3 days of real-world case studies, this summit will provide the roadmap to augmented R&D decision making with reduced failure rates, increased speed and improved margins.

This year’s summit will take a deeper look at:

•  Target, pathway and molecule selection – identifying which will treat individual disease indications better
•  Predictive preclinical models – knowing from the beginning how drug candidates will react when administered to in vivo and in vitro models
•  Identification of the patients who will react best to the treatment with minimal side effects for a guaranteed successful clinical trial

The Only Event In Asia Providing The Latest Science, Technology And Partners To Accelerate Antibody & Protein Therapies, Adcs, Bispecifics And Immuno-oncology.
 

World-renowned scientists sharing the latest technologies, R&D and clinical data to fast-track your next-generation therapeutics towards commercial success

Conferenceseries LLC Ltd is very excited to welcome participants to Rome, Italy at Pharmaceutical Nanotechnology and Nanomedicine scheduled during February 24-25, 2020.

Nano Pharmaceuticals 2020 will illustrate innovative research ideas on Nano medicine & Nanotechnology, Pharmaceutical Technology, Drug Delivery, Medical Devices for Drug Delivery, Biotechnology ,Nanorobots and Formulation Technology, This conference presents a fantastic line-up for many international experts such as Professors and Ph.D Scholars from academia, Clinicians, R&D Scientists, CEOs, CROs, CMOs, Director, President from Pharmaceutical Companies, Manufacturers, Distributors and Suppliers of Drug Delivery Technologies, Business Entrepreneurs, Health professionals & Pharmacist, Quality control specialist. It provides interdisciplinary platform to present and discuss the most recent innovations, trends as well as practical challenges encountered and solutions adopted in the fields Nanomedicine & Nanotechnology.

The global Nanomedicine market is estimated to reach USD 170 Billion in 2020, growing at a CAGR of 8.9% from 2016 to 2020, according to market research report Nanomedicine Market 2016-2020.

Welcome to the “20th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry” Conference at Dubai, UAE during February 24-25, 2020.

The Conference will carry out upon the theme “New Challenges in Pharma Industries and Growth of Pharmaceutical Research”

DUPHAT is the premier Pharmaceutical and Technology event in the Middle East launched in 1995 by INDEX® Conferences and Exhibitions Org. Est., a member of INDEX Holding in collaboration with the government through the Dubai Health Authority with the aim to provide a high-quality conference and a wide-ranging exhibition.

Neonatology 2020 features outstanding and internationally renowned neonatologists, perinatology experts, paediatricians, academicians and researchers. The representations include premier medical universities, hospitals and healthcare/pharma industries from all around the globe. The topics covered at the conference would range a spectrum of Neonatology, Perinatology and Pediatrics. Attendees of the conference would be delighted to witness various interactive workshops, keynote lectures, speaker talks, and poster presentations and most significantly the exhibitions held by the top healthcare and pharma industries. The conference also has Young Research Forum, where the budding researchers are encouraged to give oral presentations.

Join 5,000 key suppliers and buyers at CPhI South East Asia - the region's leading pharma solutions event.

Our event offers you the chance to do business in a booming and expanding market, meet the movers and shakers of the South East Asian pharma industry and keep up to date with trending news and topics.

The exhibition hosts a wide range of networking opportunities to grow your business including dedicated Forums, Product Showcases, Technical Seminars and much more.

Euroscicon welcomes every one of the members from everywhere throughout the world to go to "eighth Edition Of International Conference On Pharmacognosy and Medicinal Plants" during March 09-10, 2020 in Rome,Italy which incorporates brief keynote introductions, Oral talks, Poster introductions, Symposiums, Workshops and Exhibitions.
 
This Pharmacognosy program incorporates the paper of giving insights of physical, organic and synthetic properties of medications and items that are gotten from normal source. This arrangements with every one of the parameters of restorative, conventional and furthermore natural plants. Normal items from various plant sources will be talked about with their explanatory structures.

In order to effectively evaluate any new business development opportunities and ensure that the true value of a transaction has been realized, while forecasting the probability of both development and commercial success, life science companies need to ensure the right internal experts are involved in the evaluation process. This calls for the development and continuous improvement of a formal process that will allow organizations to efficiently and effectively evaluate, negotiate, manage, and close a transaction. The 2nd BD&L Summit serves as an open forum for cross-functional business development teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements and M&A deals.

Building on the success of our Lab Asset & FM event (LAFM) in the US, we are now looking to support the European community!

The inaugural launch of Critical Asset & Facility Management in Pharma Summit will capture current priorities amongst R&D and production asset and facility managers in the pharma and biotech sector, and help them regain control of inventory visibility, optimise spends and mitigate risks.

As the industry undergoes transformation, streamlined operations and implementing digital solutions are at the front of mind for our community. The 3-day agenda is designed to help spark conversations and provide you with the practical takeaways on:

•  Utilising tracking of critical assets to upgrade your existing asset management programme and improve inventory visibility
•  Implementing Integrated FM in R&D and production environments to streamline and optimise operations
•  Adopting IoT and digitalisation solutions to revolutionise the lab and production environments
•  Optimising asset lifecycle management to reduce costs, improve sustainability and reduce risk
•  How to more effectively use asset utilisation data to make informed decisions
•  Better evaluate and managing OEM partnerships to reduce unplanned asset downtime

After a successful conference of Pharmaceutica 2019, Pharma Conferences team cordially invites participants from all over the world to attend "21st International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems"  (Pharmaceutica 2020) slated on March 11-12, 2020 at Rome, Italy. This Pharmaceutics Conference includes a wide range of Keynote presentations, Oral talks, Poster presentations, Symposia, Workshops, Exhibitions and Career development programs.

Novel drug delivery systems Conference is one of the well-established conference among Pharmaceutical Conferences organized by Conference Series llc Ltd

Pharmaceutica 2020 covers various aspects of Bio-Pharmaceutics, Pharmaceutical Chemistry, Drug Targeting and Design, Pharmacokinetics and Pharmacodynamics in Drugs, Pharmaceutical Formulation, Pharmaceutical Manufacturing, Pharmaceutical Nanotechnology, Novel Drug Delivery Systems, Smart Drug Delivery Systems, Nanomedicine and Biomedical Applications, Biomaterials in Drug Delivery, Vaccine Drug Delivery Systems, Medical Devices for Drug Delivery, Biologics & Biosimilars, Pharmaceutical Analysis, Pharmaceutical Process Validation, Pharmaceutical Packaging, Clinical Trials and Clinical Research, Pharmacogenetics and Genomics, Regulatory Affairs and Intellectual Property Rights, Industrial and Physical Pharmacy, Clinical and Hospital Pharmacy, Pharmacovigilance and Drug Safety, Pharmacy Education and Practice

SMi group presents the launch of the inaugural AI in Drug Discovery conference taking place in London on 16th-17th March, 2020.

AI-empowered machine learning technologies hold the potential of reducing drug discovery associated costs by US$ 70 billion in the upcoming 10 years. With an estimated +39% CAGR, AI in drug discovery is leading the way into a shorter, cheaper and more successful R&D era where compound generation is automated, drug synthesis is predictable and undruggable diseases are finally being targeted.

The presence of AI in drug discovery is tangible with the majority of drug discovery scientist already working with AI-enabled platforms using machine learning and deep learning, neural networks and natural language processing. However, there is a long journey ahead of optimizing AI-human connections and understanding the full potential of AI-enabled tools and platforms.

Those who work in the field know that there is no AI revolution without tackling the field’s number one challenge: DATA. It is crucial now more than ever to come together and discuss strategies to achieve data revolution for further advancing R&D.

Join us at SMi’s inaugural AI in Drug Discovery 2020 Conference and explore the latest AI-enabled approaches for lead compound screening, multi parameter optimization, disease modelling, drug synthesis and design.

Gathering 20,000+ pharma professionals from 65+ countries worldwide, CPhI Japan is the ideal business platform for international pharma professionals to join in order to grow business in the rapidly changing Japanese pharmaceutical market. Hosting 550+ exhibitors from ingredients, contract services and biopharma through to technology, packaging and machinery - CPhI Japan and co-located events is your ultimate one-stop-shop to find the latest Japanese pharma solutions.

Taking place on 17 – 18 March 2020 in Berlin, ProcureCon Pharma is your only opportunity to benchmark with the leaders of pharma procurement.

Join 120+ senior procurement professionals from Merck, Astra Zeneca, Roche, Sanofi, Lonza and other world leading Pharma businesses over 2 days and 40 interactive sessions that will help you make better outsourcing decisions, speed up transformation, co-create value with business partners and unlock more innovation from suppliers. To learn more aboutProcureCon Pharma, download the agenda.

Take away answers to all of your top challenges:

•    Deliver on and communicate value-added procurement activities to increase credibility as a business partner
•    Identify and adopt eProcurement technologies to modernize procurement
•    Move from buyers and sellers to long-term strategic partners through SRM and Supplier-Led Innovation

For more information including the incredible speaker line-up, download the agenda here:  http://bit.ly/2mfBJuy

The International Pharmaceutical Cold Chain Management Congress will help you to ensure cost-effective, GDP compliant and secure temperature controlled supply chain and will provide a unique chance to identify solution providers who will help you in achieving that.

We have included meet the expert session which will give you an amazing chance to interact with your peers and hear about the solutions for specific challenges and how the leading experts will share their advice in tackling these challenges, in addition to that we have included interactive workshops and courses which are tailored to specific needs and will give a practical take away message from the industry experts.

Don’t miss this opportunity for such a unique congress in our region.

Oxford Global is proud to present the highly anticipated 3rd Annual Formulation & Drug Delivery USA Congress to be held in San Diego, USA. The conference programme consists of world-class keynote addresses, industry-led presentations, as well as extensive networking opportunities, creating an interactive platform for high-level scientific and business discussions

Over 300 delegates representing leading pharmaceutical organisations, biotech companies internationally renowned research & academic institutions will be present

Over 55 case studies and presentations focused on exploring challenges and solutions in formulation and drug delivery of small and large molecules. This includes the latest strategies for optimizing pharmaceutical formulations, new drug delivery systems including nano & RNA delivery, Quality by Design for continuous manufacturing and processing, and the bioanalysis, characterisation and stabilisation of drug products

Join more than 500 digital pharma marketers, technologists, and digital agencies at ePharma 2018 to discuss the ongoing digital evolution of marketing practices in pharma and biotech and the continual digitization of the patient and HCP journeys.

ePharma is a long-standing platform known to spark insightful conversations and inspire through instructional case studies, out-of-industry perspectives, and leading-edge technology, providing attendees with strategies and tactics to grow as leaders, embrace disruption, and seize innovation.

Injectable drug delivery is considered one of the most effective routes of administration due to the speed and effectiveness of delivery to the target, as well as the improved patient experience. The global injectable drug delivery market continues to grow and technology is advancing. This, coupled with the ever-changing regulatory requirements, means that it is imperative for companies to stay abreast of the latest developments and challenges within the industry in order to remain compliant, as well as gaining a competitive edge.

This seminar has been designed for all those working in the industry to discover the next generation of injectable drugs and devices and get an update on the latest trends, technologies and applications. Attending this event will provide a great opportunity to network with industry leaders, as well as like-minded professionals, to share common experience and best practice.

ConferenceSeries Ltd is a renowned organization that organizes highly notable Pharmaceutical conferences throughout the globe. Currently we are bringing forth “3rd International Conference on Pharmaceutical Research & Innovations in Pharma Industry” (Pharma Research 2019) scheduled to be held during March 23-24, 2020 at Barcelona, Spain. The conference invites all the participants across the globe to attend and share their insights and convey recent developments in the field of Pharmaceutical Research and Innovations in Pharma Industry.

ConferenceSeries Ltd organizes a conference series of 1000+ Global Events inclusive of 1000+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

The 5th Innate Killer Summit is the leading industry meeting providing a platform for leaders in the NK, gdT and NKT fields to network, interact and learn. This 3-day meeting is the only end-to-end platform that fosters the transformation of leading science to life-changing commercial therapies.

As the understanding of innate cells improves year on year, the challenges of producing effective cell therapies are top priorities to overcome. Manufacturing processes need to be streamlined and regulatory landscapes better understood. It is imperative that we come together as a community to exchange ideas and overcome the hurdles of getting the best immunotherapies to patients in need.

In addition to accessing cutting-edge novel innovations and the latest clinical data, leave the Innate Killer Summit fully equipped to progress your cell therapy pipeline with actionable insights and a forward-looking plan for global manufacturing.

Join world renowned academics and industry experts from all the key stakeholders to identify future approaches and deliver commercially viable off-the-shelf therapies.

The importance of the pharmaceutical industry in the modern-day society cannot be overstressed especially as there are new diseases springing up from different areas, strengthening the importance of adequate drug research and development activities. However, with the growth of the industry, comes the increase in fake drugs. In recent times, these products are still being produced and passed down to consumers in large quantities amidst the impact of the various counterfeiting hubs that have been seen to operate on a global scale. According to World Health Organization (WHO), about ten to thirty percent of the pharmaceuticals distributed to most third world countries are fake and this industry is growing at an alarming rate, even faster than legitimate pharmaceutical companies raking in about $217 billion yearly in sales. No nations stay untouched by this issue, what was once viewed as an issue endured by developing nations has now turned into an issue to developing nations including US and Europe. We require both countrywide and industry-level participation, and in addition public and private sector coordinated effort, to identify and definitively battle counterfeiters. The upcoming regulations are meant to secure the pharmaceutical supply chain and comes as a result of rising drug related criminal activities and supply chain inefficiencies.

 
To protect your brand and build a genuine future, Corvus Global Events invites you to 3rd Annual Pharma Security World 2020 – Supply-Chain, Drug Serialization and Anti-Counterfeiting Conference, which will have Pharma industry experts sharing various challenges faced, new strategies, case studies and use of innovative ideas and the conference will also offer opportunities to encourage partnerships and collaborations.
 

It gives us a great pleasure to welcoming you to the 3rd Annual Pharma Security World 2020 - Supply-Chain, Drug Serialization and Anti-Counterfeiting Conference.

It is a big pleasure to invite you to the 2020 EAHP Congress, hosted by the beautiful city of Gothenburg. Gothenburg, or Göteborg in Swedish, is Sweden's second most populated city and capital of Götaland. It might be colder by climate, but it has a warm and charming atmosphere, friendly and open citizens. A city with an intense history, famous for Scandinavia's largest harbour, blue trams and as a home of the best known Swedish automotive industry brand.

For hospital pharmacists, another chapter of the profession's history will be written in 2020, when Gothenburg hosts the 25th Congress of the European Association of Hospital Pharmacists (EAHP). "Hospital Pharmacy 5.0 – the future of patient care", as the Congress' main headline sounds, hints at an exciting glimpse to the future of our profession. Indeed, the Congress participants will have an excellent opportunity to learn about and share their experience with the latest advances in technologies that will shape the way how pharmaceutical care in hospitals will be delivered in the upcoming decades. Artificial intelligence, mHealth, 3D printing, personalised medicine, all of these will influence our work towards the optimal outcomes for our patients and have the potential to change our workflows profoundly. The Congress will also cover the ongoing challenges in our work, like tackling antimicrobial resistance, delivering seamless care, raising the quality of hospital pharmacy compounding, advances in clinical pharmacy or the role of hospital pharmacists in the multidisciplinary teams in hospital and on the interface with community or outpatient settings, just to name a few. We know that you expect high-quality scientific content from the EAHP Congress, and the EAHP works hard on delivering the programme that will meet your expectations and needs.

Nevertheless, the EAHP Congress is not just a scientific event – it is also an opportunity to meet colleagues from different countries in Europe and around the globe. While we may encounter many differences in the healthcare systems, human and economic resources available in our hospital pharmacies, the patients' needs are universal, and we can inspire each other. So do not miss an opportunity to meet old and new friends in Gothenburg, to bring home new knowledge as well as skills and to use them for your patients. See you in Gothenburg!

LexisConferences is delighted to invite all to the upcoming World Biosimilars & Biologics Summit 2019 which is going to be held on March 27-28, 2020 at Newyork, USA.

Biosimilars Summit 2020 is a phenomenal event which will be bringing together people from different domains of pharmaceutical and biopharmaceutical world such as Researchers, Analysts, Pharmacists, Pharmacovigilants,  Regulatory and IPR Attorneys, Business Development Teams, Professors, PhD research scholars and more to discuss on the topics related to Biosimilars and Biologics. This international event also includes Keynote talks, Plenary sessions, Young Investigators Forum, Special Sessions, Panel Discussions, Exhibitions, Poster Presentations, Workshop and Symposiums.

Biosimilars Summit 2020 aims at providing opportunities to all its Speakers and Delegates to come together to interact and exchange new ideas related to biosimilars, biologics, biopharmaceuticals and more. This conference will provide all our participants Business 2 Business sessions, where they will be able to reach out and make a mark for themselves globally.

The Global biosimilars market is expected to reach USD 23.63 Billion by 2023 from USD 4.49 Billion in 2017, at a CAGR of 31.7%. By far European Countries dominate the market owing to the favorable government regulations in this region representing 80% of global spending followed by USA which approximately covers around 50% global biologics market and coming to Asia it is expected that in the next 5 years global pharmaceutical spending will rise upto 43% from a roughly 38%.

For 24 years, DDP has been the world’s largest drug delivery meeting place to accelerate drugs to market and lengthen lifecycles for long term profitability by finding new partners, new drug delivery technologies, and new formulation development strategies.

As one of the most impactful pharmaceuticals for maintaining public health, antibiotics have been around since early 20th century and have since shown a need for significant progress in recent years. This is mainly due to its broad and indiscriminate use which has slowly given birth to multi- to extensively-drug resistant bacteria rendering our current last-resort antibiotic arsenal, including colistin, carbapenems, 3rd and 4th generation cephalosporins, useless.

This year’s event aims to showcase a suite of sessions focused on novel drugs and approaches, particularly highlighting non-traditional and traditional therapies that provide an innovative means to spearhead the issue. The conference will also place significant emphasis on the much-needed support for innovative approaches such as sessions tackling the funding and support and the regulation that provides guidance towards the goal of ameliorating the continued rise of anti-microbial resistance AMR.

It is crucial to bring industry leaders together to discuss the strategies in place that reduce AMR, evaluate the role pharmaceutical companies and funding bodies play in reducing AMR, learn about new diagnostics approaches to identify AMR and consider novel candidates and alternatives to anti-microbials. Join us in March 2020, along with leaders from the pharmaceutical industry, academia, regulatory and funding bodies, and public-private partnerships to discuss the way forward.

The 4th Annual Gene Therapy for Rare Disorders will focus exclusively on overcoming the late-stage commercial challenges drug developers face when delivering gene therapies to market.

With approvals in a number of indications over the last year, and more rapidly approaching on the horizon, the meeting will leverage the experience from first to market pioneers, as well as unveiling the strategies
drug developers are employing to improve efficacy, safety and commercial viability.

Incorporating insights from 80+ industry-leading speakers, this conference will delve into the key regulatory, reimbursement, clinical and manufacturing hurdles that need to be overcome to realize the commercial potential of gene therapies.

Join 600+ of your colleagues to accelerate the progress of the next generation of gene therapies.

Being a pharmaceutical leader was once all about what you could sell. Marshalling your troops like a grand army, ready to fight for your share of voice. Today, we need a new kind of leadership – one that is authentic, all about data-driven decision-making, regulatory-grade real-world evidence, value-based access and empowering medical on the front line.

To affect this change, 2000+ pharma-decision makers (from across Commercial, Sales, Marketing/Digital, IT, Medical, Patient Engagement, Market Access, RWE and Clinical) will join heathcare innovators on their yearly journey to the 18th eyeforpharma Barcelona Conference.  Let's usher in a new era of collaboration and truly achieve value-based care.

analytica is the International Trade Fair for Laboratory Technology, Analysis and Biotechnology. Our unique exhibition profile combines all the aspects of modern analysis employed in industry and research. Gain a complete overview of the market by attending the analytica conference and our practice-oriented supporting program. Join us out in front.

Being a pharmaceutical leader was once all about what you could sell. Marshalling your troops like a grand army, ready to fight for your share of voice. Today, we need a new kind of leadership – one that is authentic, all about data-driven decision-making, regulatory-grade real-world evidence, value-based access and empowering medical on the front line.

To affect this change, 2000+ pharma-decision makers (from across Commercial, Sales, Marketing/Digital, IT, Medical, Patient Engagement, Market Access, RWE and Clinical) will join healthcare innovators on their yearly journey to the 18th eyeforpharma Barcelona Conference. 

The Annual Pharma Supply Chain and Security World Summit is back in London for the 3rd time, and this time with more focus on optimizing your supply chain challenges to ensure an agile, responsive, streamlined and secured supply chain. Pharmaceutical companies have to resist the challenges looming from supply chain security lapses to avoid infiltration of counterfeit, diverted, and adulterated drugs entering into the supply chain. Apart from having an end to end visibility and traceability within the supply chain, an effective serialization programs will be a key differentiator and will be a competitive advantage for the pharmaceutical companies. Drug counterfeiting which is not only a global public health risk, but also harm the quality of the product, the integrity of the brand, the economy and even national security. Revenues from the pharma and bio-pharma counterfeit market is estimated to be more than $200 billion. Aligning your anti-counterfeiting strategy with the corporate supply chain strategy should plot a roadmap for implementing anti-counterfeiting measures.
 

Both industry and governments across the world recognising the importance of implementing product serialization, it becomes obligatory for all entities within the supply chain to comply with federal or state legislations pertaining to the locations in which they operate.

Gavin Conferences invites participants from all over the world to attend “International Summit on Pharmacology and Drug design”. Pharmacology 2020 is a two-day congress going to be held at Hong Kong from April 06-07, 2020 and is open to attendees, academics and non-academic audiences.

The Theme of the congress is " Scientific breakthroughs and discoveries in drug action".

The two-day conference is designed to bring researchers, academicians, doctorates, professors, lecturers and scholars to discuss research and share ideas regarding career interests to make event experience even better. During the event, participants can build networks and share information and ideas with one another.

Gavin Conferences invites participants from all over the world to attend “International Conference on Pharmaceutics and Drug Therapeutics”. Pharma 2020 is a two-day congress going to be held at Hong Kong from April 06-07, 2020 and is open to attendees, academics and non-academic audiences.

The Theme of the congress is " Advancements in Drug Development & Research".

The two-day conference is designed to bring researchers, academicians, doctorates, professors, lecturers and scholars to discuss research and share ideas regarding career interests to make event experience even better. During the event, participants can build networks and share information and ideas with one another.

As the only meeting catered to the needs of senior R&D Procurement, Sourcing and Category Management leaders, we have seen the transformation since we launched this meeting in 2017. Over the last 3 years, we have witnessed the industry begin to mature – procurement leaders play an increasingly important role as strategic business partner and innovation enabler, supporting R&D to progress into clinic and commercialization.

Be part of this growing community where you can share your common challenges and be inspired by fellow colleagues from pharma and biotechs.

The 5th year of the Emirates Forum of Urology will be held in collaboration with the 4th Middle East Masterclass of Men’s Health hosted by the Sheikh Khalifa General Hospital.

Over two days, the Forum will bring to you a remarkable group of regional and international surgeons, urologists, specialists and consultants from across the globe to share their updates in the management of men’s health related diseases with special focus on Erectile Dysfunction, Peyronie’s Disease and Prostate.

Join us in Dubai for the Plenareno Heart Congress 2020 with the alliance of esteem Cardiology Organizations and Societies. Plenareno Heart Congress is designed to meet the educational needs of cardiologists, cardiac surgeons, pediatricians, nurses and all other related healthcare professionals who manage individuals with heart & cardiovascular complications.

The Plenareno Heart Congress program, presented by distinguished speakers, will focus on daily management of heart arrhythmias, including interactive workshops and plenary sessions, chaired poster presentations and oral sessions. It provides an excellent opportunity for students, internists and young scientists with comparable levels of experience to represent their ideas, explore cutting-edge research and to network with the next generation of cardiologists and researchers. Gain advanced knowledge, expanding your insight and exposure to the newest ideas through a multitude of presentations.

All the participants will have the chance to benefit from scientific exchanges during either formal activities or informal meetings with experts and investigators from different areas focused on cardio-care and emerging technologies for heart diseases.

Brought to you by the organisers of Arab Health, India Health presents an opportunity to all stakeholders in search of a platform that facilitates business interaction, learning and development, and access to the right healthcare entities, authorities and associations in a fast-emerging economy.

MASS East 2020 will provide a platform for Medical Affairs executives and professionals to share best practices, strategic insights, and collaborate with over 300 Professionals to advance communication techniques, build out your Medical Affairs organization, prepare for launches, and discover new technologies to track progress and keep customers engaged in a digital world.

It is a great pleasure and an honor to extend to you a warm invitation to attend the International Congress and Expo Meet on Pediatrics & Neonatology, to be held April 16 – 17, 2020 in Czech Republic, Prague. We sincerely welcome all the eminent researchers, students and delegates to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future revolutions  in the field of Pediatrics. Pediatrics 2020 will be sorted out around the theme “To Promote Excellence in Pediatrics Research and Child Health".

Pediatrics is the branch of medicine concerned with the development, medical care, and diseases of babies, children and adolescents from birth up to the age of 18. The aims of the study of pediatrics is to reduce infant and child rate deaths, command the spread of infectious disease, promote active lifestyles for a long disease-free life and help simplify  the problems of children and adolescents with chronic conditions.
Pediatrics 2020 provides two days robust discussions on methods and strategies related to diagnosis, prevention and management of pediatric diseases as well as explore new ideas and concepts on a global scale and the topics include pediatric immunology, pediatric hematology and oncology, pediatric allergy, neonatology, pediatric cardiology, pediatric neurology, pediatric psychology and pediatric emergencies. The conference also welcomes the participation of Presidents, CEO’s, Delegates and industrial executives from Pediatric Pharma and Health care sectors making the conference a perfect platform to network, share views and knowledge through interactive keynote, plenary, poster and B2B discussions.

Advanced Chromatography 2020  organizing committee invites analytical expertise, researchers, professors, scientific communities, delegates, students, business professionals and executives to attend the “International Conference & Expo on Advances in Chromatography & HPLC Techniques” which is to be held during April 20-21,2020 Berlin, Germany.

In the light of this theme, the conferenceseries aims to provide a forum for international researchers from various areas of analytical chemistry, pharmacy, pharmacology, bioinformatics and other life science groups by providing a platform for critical analysis of new data, and to share latest cutting-edge research findings and results about all aspects regarding advances in HPLC and Chromatography techniques.

The conference provides a platform to detail the research works of analytical expertise from various scientific backgrounds and the same can be perceived by young researchers and students. The conference mainly aims to promulgate knowledge on chromatography and unveil the advances in HPLC techniques. Both Life Sciences and Chemical Sciences need analytical techniques in course of research work and therefore Advanced Chromatography 2020 would be a perfect venue to share and develop knowledge on key analytical tools.

Arrowhead Publishers is pleased to announce the return of its 6th Annual Translational Microbiome Conference to Boston on April 21-23, 2020, taking place at the Westin Copley Place. As the official conference of The Microbiome Coalition (TMBC), the Arrowhead Translational Microbiome Conference was the first microbiome conference in the field to focus exclusively on the hurdles and challenges to commercial success in the space.
 

Once again, the conference will bring together the leading microbiome companies working to successfully commercialize microbiome-based diagnostics, therapeutics, adjunct therapies and direct-to-consumer services and products across a range of therapeutic areas, from gut to skin and beyond. Expanding on this core focus year on year, we continue to offer informative, hands-on workshops, panels sponsored and directed by industry to focus on your concerns and tightly curated content that goes beyond the usual infomercials to provide tangible and useful insights to how your peers are addressing their commercial approach to the space.
 

Entering its 6th year in 2020, the meeting will continue to focus and build on the challenges and hurdles that companies working in the microbiome space will have to recognize and navigate in order to successfully commercialize their products. With a broad focus spanning multiple disease states (oncology, dermatology, inflammatory disorders, among others) attendees will have the opportunity to hear the leading companies discuss the work they have underway and how they are meeting these challenges head-on to apply recent discoveries to a variety of disease processes, restoration of health and improved outcomes.
 

Where the top minds in pharma supply chain, logistics, distribution, planning, IT, quality and sourcing meet to share practical insights on how to achieve digitalisation, end-to-end visibility, customer-first strategies, and much more!

With over 950+ pharma supply chain leaders exclusively in one place at one time, this is THE meeting place to benchmark your business with the best and shape the future of your industry.

Welcoming over 300 key leaders across 3 cutting-edge programmes, looking at new strategies for optimizing biologic formulations such as antibodies, proteins and vaccines, the latest developments in inhaled vaccines and antibiotics, and the challenges at the forefront of biomanufacturing research; from cell & gene therapy and biologics biomanufacturingthrough to upstream and downstream bioprocessing

Drug Delivery 2020 promises to revolutionize our lives through the approaches of discussion & research work about the new medicine, various dosage form, their formulation, route of administration, Efficacy, interaction, mechanism of action within body & their pharmacological, therapeutic effect & some post marketed study like adverse drug effect, patient acceptance. The conference organizers aim is to gather the doctors, professors, researchers, students, other faculty members, academicians, pharmacists, experts and scientists from the pharmaceutical field and Novel drug delivery community to create an opportunity of global exchange of information on technological advances, new scientific innovations, patient comfort, therapeutic effect of drug and the effectiveness of regulatory programs, application, future prospects, importance of the novel drug delivery system.

The pharmaceutics and drug delivery sectors are rapidly transforming into a new level with the development of new technologies and innovative therapeutics. It is further forecast to have a tremendous growth and major changes in upcoming years. Pharmaceutics and Advanced Drug Delivery Systems provides a wonderful platform for interconnecting all these aspects to exchange technological & scientific knowledge to enhance the skills and awareness of scientific community for the betterment and well-being of society.

Over 450 proteins, antibodies, peptides and biosimilars & biobetters attendees representing global pharmaceutical organizations, leading biotech companies and internationally renowned academic institutions

Over 50 case studies, presentations and panel discussions focused on the key issues in protein and antibody engineering & development, alternative scaffolds, protein & antibody biotherapeutics as well as biotherapeutics manufacturing and chemistry.

SMi are proud to announce the 7th Pre Filled Syringes East Coast conference taking place on 27th and 28th April 2020.

The global pre-filled syringes market was valued at $4.9 billion in 2018 and with the rapid growth of the industry, is expected to exceed $9.7 billion by 2025. With that in mind, this event will bring together specialists within the industry to provide an exclusive insight into the sphere of regulation, new digital technology trends, human studies and innovative design and delivery systems within the prefilled syringe industry.

This comprehensive overview will help attendees understand the changing global market and the challenges faced within the industry

• Biologics Manufacturing, CMC & Continuous Biomanufacturing
• Cell & Gene Therapy Manufacturing: Insights, Key Strategies & Novel Approaches
• Upstream Processing, Digitalisation, Smart Factories, Tools & Technologies
• Downstream Bioprocessing: Recent Technological Advancements and Latest Trends

The pharmaceutical microbiology industry has seen many changes during the progression into the 21st century. With advances in rapid microbiological methods, revisions being made to regulations in the industry, enhanced knowledge of the human microbiome, and novel testing methods, innovative approaches in ATMP facilities, this industry is ever expanding.

Join industry experts to discuss and analyze the latest advances and challenges within the industry. Network with industry professionals, discuss revisions in regulatory and guidance documents, explore data integrity considerations for conventional and rapid microbiology methods, analyze arising issues with environmental monitoring to best control contamination and gain insight into an industry perspective on automated endotoxin testing and process automation.

Pharma industry leaders gather annually at CPhI North America to discuss pharmaceutical manufacturing, outsourcing, R&D, drug delivery and supply chain related topics for small and large molecule finished drugs as well as advancements in bio-manufacturing.

After the successful completion of the 2nd International Conference on Pharmaceutical Analysis & Analytical Chemistry, LexisConferences  with great pride and honour announcing its 3rd International Conference  on Pharmaceutical Analysis & Analytical Chemistry which is going to held in Vancouver, Canada during May 8-9, 2020. This Conference is mainly focused on the THEME: “Collaboration of advanced Pharmaceutical Analytical Techniques”.

This time Pharmaceutical Analysis 2020 want to bring huge number of participants from around the globe focused on learning about Pharmaceutical Analytical Techniques and its advances. This is your best opportunity to reach the largest assemblage of participants from Pharma research community that is from academia, Analytical entities, Laboratory Technical Departments, regulatory agencies, R&D departments, related associations, societies and also from government agencies, pharmaceutical, biomedical and medical device industries.

Pharmaceutical Analysis 2020 will discuss various disciplines involved in the field of Pharmaceutical Analysis & Analytical Chemistry procedures and Validation it will educate health care researchers about design, operation, organizing, research computing, regulatory aspects and reporting of Analytical Techniques. This conference conduct presentations, distribute information, meet with current and potential scientists, make a splash with new Pharma analytical research developments, and receive name recognition at this 2-days event by sharing and Exploring of Knowledge in Present trending Research field of yours. You can also find out how innovators are minimizing the gap between product development and adoption, conduct demonstrations, distribute information, meet with current Scientists, and make a blazon with a new research, in Pharmaceutical Analysis and its Techniques.

This Conference serves as a Stage for the international experts in the area of pharmaceutical analysis and analytical chemistry throughout the world. We cordially invite all the eminent Scientists, researchers, students, industry representatives, Business entrepreneurs & academicians, working in these exciting areas. All come together to Share or explore their Research works and Ideas, Special welcome to the delegates in all fields to gain or gathering of some information for their future.

Gastroenterology is a specialty of medicine which deals with the study, diagnosis & treatment of digestive system disorders. These disorders may affect the stomach, intestines, esophagus, gallbladder, liver, rectum, or pancreas. It is usually known as GI (Gastrointestinal). Gastroenterologists diagnose & treat Gastrointestinal diseases in an individual. The specialist performs different procedures like endoscopic in which specialized instruments are used to view the Gastrointestinal tract and make a diagnosis.The specialist can treat any part of the system. The Gastrointestinal System digests food absorbs nutrients and removes waste.

GI System includes organs like Pharynx, esophagus, stomach, small intestine, large intestine, liver, gallbladder, pancreas, salivary glands, tongue, epiglottis, rectum, anus. Gastroenterologists treat acid reflux, hepatitis C, ulcers, hemorrhoids, bloody stools, jaundice, colon cancer, etc. They perform endoscopic ultrasounds, colonoscopies, endoscopic retrograde, sigmoidoscopies, liver biopsies, capsule endoscopies, double-balloon enteroscopy to examine different organs of the body.

Nursing includes intensive care, prevent illness, monitoring and observeing the patient and record the relevant information to assist in treatment and decision making. It is a branch within the healthcare sector which is focused on the intensive care of communities, families, and individuals so they can live the quality of life. Nurses educate people about health, provide them treatments, medication, and advice to the patients, and support the family members of the patient.

They work collaboratively with therapists, physicians, patients, and their family and other team members. Nursing is a field that holds together a patient’s health and care. Over the entire patient experience and whenever there is someone who needs care; nurses work indefatigably to protect and identify the needs of the person. Nurses ensure the most explicit diagnosis to the ongoing training, education of people about medical issues; nurses play a crucial role in safeguarding public health.

Due to the wide range of complex skills, specialism, and care. Each nurse will have expertise, passions, strengths. Nurses provides an intensive care to the patients until they maintain or recover optimal health. To run a healthcare system, the whole team of specialists, professionals, nurses work together. In some cases, nurses even fill the role of doctors. They play an essential role in clinics, hospitals, and private practices and communicates between doctors and patients, patient care, providing medicine and supervising nursing aides.

Healthcare is the improvement and maintenance of a person’s health via the diagnosis, prevention, surgery, the administering of medicine, injury, and other mental and physical impairment in people. In this field, specialist work to help people get healthy.

These services are offered through healthcare professionals in the allied health field. Trained and Licensed professionals help people to maintain or restore mental, physical, or emotional breakdowns. Nurses and doctors are the best-known Healthcare professionals. Physician assistants, Speech therapists, Administrators, and many more professionals belong to the Healthcare Industry. These may work in patient’s home, the military, hospitals, nonprofits, or education.

Diabetes is a disease in which the level of blood sugar or blood glucose are too high. It involves problems with the hormone insulin. The pancreas releases insulin, which helps glucose to get into the cells to give them energy. Glucose comes from the food which we eat. Diabetes occurs when the pancreas produces insulin in small amount or no insulin or our body can’t use insulin appropriately and which causes to build up sugar in the blood. It can cause serious health issues, including blindness, heart diseases, kidney failures, and many more diseases. Diabetes is increasing day by day. High levels of glucose results into the damage of the body and failure of various tissues and organs. Symptoms of Diabetes are frequent urination, excessive thirst, a sudden change in vision, dry skin, more infections than usual, tiredness, hunger, weight loss, vomiting, Nausea or stomach pain, etc. There are three main types of Diabetes- Type 1 (can develop at any age, but mostly occurs in children and adolescents), Type 2 (It mainly occurs in adults), GDM (Gestational Diabetes occurs when there is high blood glucose during pregnancy and is associated with complications to both child and mother.

Endocrinology is a branch of medicine and physiology which involves the study of hormones and treatment of hormone-based diseases. The endocrine system consists of various glands in different parts of the body, which produces chemicals called hormones. These hormones directly secret into the bloodstream. The vital endocrine glands are pancreas, parathyroid, thyroid, adrenal, pituitary, and gonads. From these glands, hormone regulates metabolism, blood pressure, growth, reproduction, and many other vital functions. The endocrine glands are also termed as ductless glands. Where there is an imbalance of hormones, different diseases can occur, and endocrinologist deals with these types of problems. An endocrinologist can diagnose and treat hormone-based problems.

The UCG OCM would like to invite Pharmacist, experts, professors, students, practitioners, medical specialists, clinical scientists, technologists and other healthcare professionals to the Pharmaceuticals Utilitarian Conference going to be held in Berlin, Germany. Our main aim is to bring leading researchers, scientists, and research scholars researchers to exchange, discuss and share their experiences and research results about all aspects of Pharmaceuticals. This Conference aims to provide participants working in Pharmaceuticals medicine with a venue in maintaining cutting-edge knowledge and skills in their fields including Pharmacology, Pharmaceutical Sciences, Pharmaceutical Biotechnology, Smart Drug Delivery Systems, Pharmaceutical Engineering, Pharmacognosy, Digital Pharma, Clinical Pharmacy, Pharmaceutical Analysis, Pharmaceutical Chemistry, Pharmaceutical Formulations, Pharmaceutical Regulatory Science and other disciplines.

We look forward to making the Conference not only a learning opportunity but also offer a destination where you can enjoy and unwind yourself before you start your work. The Pharma Conference revolves around the theme – “Discover the World of Pharmaceuticals.” By attending the Pharma conference, you will have the chance to grow both career-wise and relation wise. Your presence will be much appreciated.

The 4th Annual Digi-Tech Pharma & AI conference brings with it even more interactive sessions, expert speakers, senior professionals and decision makers from leading pharma, bio-tech and healthcare industry. Meet the decision makers, benchmark and learn from real-life use cases to drive organizational change and to understand the new cutting-edge technologies and practical solutions. In this 4th edition as we explore the novel technologies and developments reforming pharmaceutical industry, we also dive deep into the implementation and advances in machine learning, deep learning, artificial intelligence, informatics and data science which has redefined the development of new drugs, tackle diseases, improving healthcare and much more.

The enhancements in data management and data integration are providing improvements to both the speed and quality of drug discovery and many clinical trial processes. To be in the forefront, a necessity for partnership and collaboration with healthcare provider is a must for the pharmaceutical companies, and these partnerships will also lead to massive advances in R&D using artificial intelligence in genomics and precision medicine to develop a deep understanding of the root causes of diseases.

The combination of AI, big data and IoT technologies are creating new innovations, also other eminent technologies like cloud computing, augmented reality, virtual reality and blockchain are being used extensively in the Pharmaceutical industry’s digital transformation.

It gives us a great pleasure to welcoming you to this international pharmaceutical technology conference 4th Annual Digi-Tech Pharma & AI 2020.

What makes nasal delivery systems more challenging than solid dosage forms? How safe is nasal drug delivery? Are there such things as safe excipients? How does all this fit within the regulatory environment in Europe and the USA? How difficult is it to bring all these products to market?

This seminar seeks to explore these and other questions within the field of nasal drug delivery while reviewing interesting new data, innovative technologies and the very latest scientific developments. Leading authorities in nasal drug delivery will cover relevant aspects of nasal physiology, anatomy, absorption of a variety of drugs in various phases of drug development, and new drugs entering the market. In addition, nasal delivery to the sinuses will be discussed and the programme will include interesting case histories.

This seminar will offer an excellent networking opportunity to build business relationships and discuss all these issues with an unrivalled panel of experts in this field of drug delivery.

Today’s LifeScience environment is dynamic, very changeable and requires a broad and holistic view for every manager/executive working in this environment. The LifeScience Micro MBA program is a condensed overview of all aspects with respect of doing business in a LifeScience environment which will prepare managers who have further career ambitions either in their current role/discipline or considering a switch to any other discipline in this industry. The program will focus primarily on sharing experiences and case-studies in forum discussions and exercises setup rather than classroom teaching only.

The Pharmacovigilance World 2020 conference will provide a platform for the participants to discuss, share and stay updated with present state of affairs in Pharmacovigilance and Drug safety, and contribute to the public health. It will also allow all its participants to interact with the experts, discuss the various developments, challenges faced and innovations in the field. The conference will bring-forth the participants and the representatives from various fields of pharmacovigilance and drug safety under a common umbrella, and will provide them an opportunity to network with various industry professionals including pharmaceuticals, biologics, devices, CROs and PV service providers.
 

It gives us a great pleasure in welcoming you to the Pharmacovigilance World 2020 conference.

uroSciCon outspreads its warm welcome to all its participants to European Conference on Otolaryngology, ENT Conference 2020 scheduled on June 10-11, 2020 at Frankfurt, Germany with a theme “To Emphasize the Modernity of ENT Technologies” .EuroSciCon organizes International Events with Conferences, Meetings and Workshops on Medical, Pharma, Engineering, Science, Equipment and Business.

We gladly welcome attendees all around the world for the hearing of the leading recent innovations and inventions in the field of Ear, Nose and Throat Cures. This Conference will provide a forum for exchange of ideas and authoritative views by leading scientists, trade specialists and from the academicians of the best institutes from around the globe. Settled keynote speakers and well-known leading scientists and experts from around the globe will be expected to share their awareness and talk about various aspects related to various frontlines in the field of Treatment of Ear, Nose and Throat.

Antibiotics Congress has been designed in a knowledge base manner with a large number of tracks to decide on from each phase and provides you with a novel chance to satisfy up with peers from each trade and establish a scientific network between them. We warmly invite all involved people to come be a part of us at our event and make it victorious by your participation.

The conference will be organized around the Theme ‘Scrutinizing Modern Research Developments on Antibiotics, Antimicrobial & Antibiotic Resistance’.

Our goal is to bring organized minds to give talks that are knowledge-focused, and on a wide range of topics, to foster learning, inspiration and provoke discussions that matter.

We are also pleased to announce that the Antibiotics Congress will take place in one of the most stunning cities in the world, Rome, Italy.

The International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD) is a non-profit, non-governmental association and has its headquarters in Geneva, Switzerland. ISPPD is the leading event in Pneumococci and Pneumococcal Diseases bringing together professionals in the field to raise global awareness and improve standards of diagnosis, prevention and treatment.

4th International Pharmaceutical Conference and Expo welcome you as our guest to the City of London, UK during August 05-07, 2020. The theme of the upcoming edition of i- Pharma UK  is Pharma research for Industry demands.

The annual i- Pharma conference and expo 2020 is the largest gathering of Pharma and Healthcare professionals in the UK and in Europe. i- Pharma UK is expecting hundreds of academic, research and industry leaders from 24 different countries to gather in London, the UK for this three-day meeting.

i- Pharma Congress 2020 is packed with many workshops, symposiums and multiple plenary sessions with main focus on thought-provoking discussions and peer-led networking. The conference is the ideal venue to learn about the latest trends shaping the pharma industry, to gain new skills and insights from successful pharma experts.

For i- Pharma UK, 2020 renowned academic, researchers along with industry leaders from key pharma companies will be sharing their insights into the role of Drug Discovery,  Drug Designing, Drug Development, Digital Pharma, Pharmacovigilance, Pharma Packaging, Biopharmaceuticals, Drug Delivery Systems and translating this into real life strategies for your career and business.

i- Pharma UK 2020 offers unparalleled business, research opportunities and access to new markets in Pharma and Health Care industry. Be on the cutting edge of new and often yet-unreleased information and discover an area that piques your interest.

Join us and witness the booming industry by participating at i- Pharma 2020 UK and give your career and business access to new opportunities from throughout the world.

The International Neurodisorders and Therapy Conference welcomes you to London during August 13-14, 2020 to share your research findings, encourage knowledge exchange and network with a broad audience in the field of neuroscience.

i-Neuro 2020 is an annual gathering for researchers, practitioners and educators to share the insights and discuss the recent innovations, research, issues, and development to enhance patient outcomes in those suffering from neurological disorders. iNeuro is one of the leading events for neuroscientists to present emerging science, learn from experts, forge collaborations with peers, discover new tools and technologies, and advance careers.

Research in neuroscience is continually developing based on biology, pharmaceutical science, medicine, cognitive science, and biomedical engineering. The conference’s global goal is to bring Academicians, Research & Development Executives, Scientists, Industrialists, policy makers to deliberate upon and disseminate innovative thoughts to deepen the understanding of the effects of brain disorders on health and to channel the knowledge into innovative solutions for patient care.

MEDICAL FAIR ASIA continues to be Southeast Asia's most definitive event for the medical and healthcare industry, gathering the region's hospital, diagnostic, pharmaceutical, medical and rehabilitation sectors in one convenient location and providing the perfect platform to discover the latest industry innovations, to network and do business.

Following the successful growth path since its inception in 1997, MEDICAL FAIR ASIA will see its most impressive line-up ever of medical and healthcare industry players from around the world in its 13th edition, scheduled to be held from 9 - 11 Sep 2020 at Marina Bay Sands Singapore.

The fifth edition of MEDICAL MANUFACTURING ASIA makes a return to Singapore as the region's leading specialist trade fair for Asia's medtech and medical manufacturing processes sectors.

Jointly organised by SPETA (Singapore Precision Engineering and Technology Association) and Messe Düsseldorf Asia, MEDICAL MANUFACTURING ASIA 2020 will feature an extensive product range covering the upstream and downstream processes in medtech sectors, including new materials, components, intermediate products, packaging and services, to micro and nanotechnology, testing systems and services, as well as materials, substance and components for medical technology. Industry-focused business forums will also headline the upcoming edition of the specialist trade fair.

art of the MEDICAlliance’s global network and sharing the established expertise of COMPAMED, MEDICAL MANUFACTURING ASIA 2020 is co-located with MEDICAL FAIR ASIA 2020 – the No. 1 medical and healthcare exhibition in Southeast Asia with a focus on the equipment and supplies for the hospital, diagnostic, pharmaceutical, medical and rehabilitation sectors.

Pharma Colloquium welcomes you as our guest to the Toronto during September 14-15, 2020. Pharma Colloquium 2020 incorporates about each stage of information, advancement, innovation and organizing; and has a target of making a worldwide gathering for academicians, specialists and business experts to discuss the soundest issues related to pharma, Biotech and Health Care.

This program provides two days of robust discussions in the field of Clinical Trials, Pharmaceutical Formulations and Drug delivery system, Pharmaceutical GMP, GCP & Regulatory Affairs, Medicinal Plants, Traditional Medicines and Marine Drugs, Medicinal Chemistry & Computer Aided Drug Designing, Pharmacology, Neuropharmacology, Pharma Marketing, Orphan and Rare Disease and more.

Join us and witness the booming industry by participating at Pharma Colloquium 2020 and give your career and business access to new opportunities from throughout the world.

The Summit covered both small molecules and biologics, new technologies, concepts and case studies in areas such as:

•  Formulation design for poorly soluble compounds
•  The potential of nanotechnology for better deliverability
•  The latest controlled released technologies
•  Improving patient compliance by harnessing data and the latest smart device technology
•  Optimising formulations for continuous manufacturing
•  Overcoming the blood brain barrier and challenges in oral delivery of biologics
•  Reformulation and biosimilars

The first-ever World Down Syndrome Congress (WDSC) will take place in Dubai in November 2020. This first-of-a-kind event in the Middle East and North Africa region will welcome over 1,200 experts, specialists, researchers and advocates, as well as people with Down Syndrome and their families.

WDSC will address developments and ongoing research in a range of fields related to Down Syndrome including health, education, employment, standards of living, social and legal protection, and social and cultural integration. The UAE serves as a valuable meeting point for such an occasion, considering its dedication to improving the quality of life and integration of People of Determination.